Company news
Spectral Medical Inc news in 2010
Spectral Medical Inc's news releases, calls and decks from 2010, newest first.
Spectral diagnostics completes conversion of promissory notes
December 31, 2010
Spectral obtains exclusive canadian distribution rights for Toraymyxin?
November 22, 2010
Spectral announces third quarter 2010 results
November 15, 2010
Spectral initiates U.S. pivotal trial of Toraymyxin¿ in septic shock
October 19, 2010
Spectral to present at rodman & renshaw annual global investment conference on September 13
September 13, 2010
Spectral announces second quarter 2010 results
August 12, 2010
Spectral receives McMaster Industry Partner of the Year Award for aptamer discovery research
June 23, 2010
Spectral announces first quarter financial results
May 14, 2010
Spectral announces presentations at the 8th Annual World Congress on Trauma, Shock, Inflammation and Sepsis focusing on the role of endotoxin
March 12, 2010
Spectral announces 2009 financial results
March 11, 2010
Spectral appoints two new board members
March 10, 2010
Spectral closes $19.5 million private placement financing
March 3, 2010
Spectral granted IDE approval by U.S. FDA to conduct pivotal trial for Toraymyxin(TM)
March 2, 2010
Spectral shareholders approve $19.5 million private placement financing
February 26, 2010
Spectral increases private placement financing to $19.5 million
February 3, 2010